NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC)
INFUSION PROVIDERS ALLIANCE
AMBULATORY SURGERY CENTER ASSOCIATION
FULCRUM THERAPEUTICS
ARDELYX
OWLET
AS
The past 12 months
Clients
6
past 12 months
Filings
6
past 12 months
Agencies contacted
HOUSE OF REPRESENTATIVESSENATEHealth & Human Services, Dept of (HHS)Centers For Medicare and Medicaid Services (CMS)Office of Management & Budget (OMB)
Specific issues
H.R. 2168/S.3712, Baby Observation (BO's) Act
Issues related to the 2025 End-Stage Renal Disease (ESRD) Prospective Payment System (PPS) Final Rule (CMS-105-F), specifically the inclusion of oral-only drugs in the ESRD PPS Bundled Payment. H.R.6214 - Kidney Care Access Protection Act Issues related to Most Favored Nation Drug Pricing Reform
Education and advocacy regarding emergency services and Medicare reimbursement of freestanding emergency centers, including H.R. 3134, the Emergency Care Improvement Act.
Issues relating to the implementation of provisions included in Subtitle BB of PL.116-260- No Surprises Act, including the No Surprises Act Enforcement Act (H.R. 4710/S. 2420). Issues relating to the Federal Independent Dispute Resolution Operations proposed rule
Education and advocacy regarding sickle cell disease, including H.R. 1796/S. 735- Sickle Cell Disease and Other Heritable Blood Disorders, Research, Surveillance, Prevention, and Treatment Act of 2025. Priority review vouchers: Give Kids a Chance Act of 2025 (H.R. 1262/S.932) Issues related to FDA Accelerated Approval Pathways
Advocating for access to and reimbursement for biosimilars. Issues related to vertical integration and white bagging.
Clients
Sources
This profile is built from the public record: filings in the U.S. Senate Lobbying Disclosure Act system. lda.senate.gov ↗